|
Binding of autoreactive mouse anti-type II collagen antibodies derived from the primary and the secondary immune response investigated with the biosensor technique
|
journal
|
December 1995 |
|
Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1LAI, HIV-1MAL, and HIV-1ELI
|
journal
|
December 1991 |
|
Contrasting IgG Structures Reveal Extreme Asymmetry and Flexibility
|
journal
|
May 2002 |
|
[20] Processing of X-ray diffraction data collected in oscillation mode
|
book
|
January 1997 |
|
Receptor Editing in a Transgenic Mouse Model: Site, Efficiency, and Role in B Cell Tolerance and Antibody Diversification
|
journal
|
December 1997 |
|
Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: Implications for evasion of immune responses and design of vaccine immunogens
|
journal
|
December 2009 |
|
Somatic Mutations of the Immunoglobulin Framework Are Generally Required for Broad and Potent HIV-1 Neutralization
|
journal
|
March 2013 |
|
Structural Evolution of Glycan Recognition by a Family of Potent HIV Antibodies
|
journal
|
September 2014 |
|
Immunization for HIV-1 Broadly Neutralizing Antibodies in Human Ig Knockin Mice
|
journal
|
June 2015 |
|
Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing Epitopes
|
journal
|
December 2015 |
|
Induction of HIV Neutralizing Antibody Lineages in Mice with Diverse Precursor Repertoires
|
journal
|
September 2016 |
|
Sequential Immunization Elicits Broadly Neutralizing Anti-HIV-1 Antibodies in Ig Knockin Mice
|
journal
|
September 2016 |
|
Structural Constraints Determine the Glycosylation of HIV-1 Envelope Trimers
|
journal
|
June 2015 |
|
Composition and Antigenic Effects of Individual Glycan Sites of a Trimeric HIV-1 Envelope Glycoprotein
|
journal
|
March 2016 |
|
Multidonor Analysis Reveals Structural Elements, Genetic Determinants, and Maturation Pathway for HIV-1 Neutralization by VRC01-Class Antibodies
|
journal
|
August 2013 |
|
Identification of Common Features in Prototype Broadly Neutralizing Antibodies to HIV Envelope V2 Apex to Facilitate Vaccine Design
|
journal
|
November 2015 |
|
Affinity Maturation of a Potent Family of HIV Antibodies Is Primarily Focused on Accommodating or Avoiding Glycans
|
journal
|
December 2015 |
|
Key gp120 Glycans Pose Roadblocks to the Rapid Development of VRC01-Class Antibodies in an HIV-1-Infected Chinese Donor
|
journal
|
April 2016 |
|
HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing Antibodies
|
journal
|
September 2016 |
|
HIV-1 Envelope Trimer Design and Immunization Strategies To Induce Broadly Neutralizing Antibodies
|
journal
|
March 2016 |
|
Broadly neutralizing antibodies against HIV-1: Templates for a vaccine
|
journal
|
January 2013 |
|
Binding of inferred germline precursors of broadly neutralizing HIV-1 antibodies to native-like envelope trimers
|
journal
|
December 2015 |
|
Chemical Synthesis of Highly Congested gp120 V1V2 N -Glycopeptide Antigens for Potential HIV-1-Directed Vaccines
|
journal
|
August 2013 |
|
Sulfation, the Up-and-Coming Post-Translational Modification: Its Role and Mechanism in Protein−Protein Interaction
|
journal
|
March 2007 |
|
Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals
|
journal
|
March 2009 |
|
Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation
|
journal
|
September 2010 |
|
Broad neutralization coverage of HIV by multiple highly potent antibodies
|
journal
|
September 2011 |
|
Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9
|
journal
|
November 2011 |
|
Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus
|
journal
|
April 2013 |
|
Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys
|
journal
|
October 2013 |
|
Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies
|
journal
|
March 2014 |
|
Structure and immune recognition of trimeric pre-fusion HIV-1 Env
|
journal
|
October 2014 |
|
A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges
|
journal
|
April 2016 |
|
B-cell–lineage immunogen design in vaccine development with HIV-1 as a case study
|
journal
|
May 2012 |
|
Specifically modified Env immunogens activate B-cell precursors of broadly neutralizing HIV-1 antibodies in transgenic mice
|
journal
|
February 2016 |
|
Antibody responses to envelope glycoproteins in HIV-1 infection
|
journal
|
May 2015 |
|
Role of antigen receptor affinity in T cell–independent antibody responses in vivo
|
journal
|
March 2002 |
|
Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques
|
journal
|
June 2009 |
|
Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design
|
journal
|
December 2015 |
|
Natively glycosylated HIV-1 Env structure reveals new mode for antibody recognition of the CD4-binding site
|
journal
|
September 2016 |
|
Structural basis for germ-line gene usage of a potent class of antibodies targeting the CD4-binding site of HIV-1 gp120
|
journal
|
June 2012 |
|
Structural basis for HIV-1 gp120 recognition by a germ-line version of a broadly neutralizing antibody
|
journal
|
March 2013 |
|
Affinity maturation in an HIV broadly neutralizing B-cell lineage through reorientation of variable domains
|
journal
|
June 2014 |
|
Recombinant HIV envelope trimer selects for quaternary-dependent antibodies targeting the trimer apex
|
journal
|
November 2014 |
|
Thermodynamic Analysis of the Binding of 2F5 (Fab and Immunoglobulin G Forms) to Its gp41 Epitope Reveals a Strong Influence of the Immunoglobulin Fc Region on Affinity
|
journal
|
December 2013 |
|
Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies
|
journal
|
March 2013 |
|
Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques
|
journal
|
August 2014 |
|
Progress toward active or passive HIV-1 vaccination
|
journal
|
December 2016 |
|
Cross‐Reactive Neutralizing Humoral Immunity Does Not Protect from HIV Type 1 Disease Progression
|
journal
|
April 2010 |
|
Stabilized HIV-1 envelope glycoprotein trimers for vaccine use
|
journal
|
January 2017 |
|
Prevalence of broadly neutralizing antibody responses during chronic HIV-1 infection
|
journal
|
January 2014 |
|
On the use of the merging R factor as a quality indicator for X-ray data
|
journal
|
April 1997 |
|
Coot model-building tools for molecular graphics
|
journal
|
November 2004 |
|
MolProbity : all-atom structure validation for macromolecular crystallography
|
journal
|
December 2009 |
|
PHENIX: a comprehensive Python-based system for macromolecular structure solution
|
journal
|
January 2010 |
|
HIV-1 neutralizing antibodies: understanding nature's pathways
|
journal
|
June 2013 |
|
Native-like Env trimers as a platform for HIV-1 vaccine design
|
journal
|
January 2017 |
|
Germline-targeting immunogens
|
journal
|
January 2017 |
|
Human Ig knockin mice to study the development and regulation of HIV-1 broadly neutralizing antibodies
|
journal
|
January 2017 |
|
The HIV-1 envelope glycoprotein structure: nailing down a moving target
|
journal
|
January 2017 |
|
Antibody-virus co-evolution in HIV infection: paths for HIV vaccine development
|
journal
|
January 2017 |
|
Structural Basis of Immune Evasion at the Site of CD4 Attachment on HIV-1 gp120
|
journal
|
November 2009 |
|
Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target
|
journal
|
September 2009 |
|
Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01
|
journal
|
July 2010 |
|
Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding
|
journal
|
July 2011 |
|
Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing
|
journal
|
August 2011 |
|
Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors
|
journal
|
March 2013 |
|
Antibodies in HIV-1 Vaccine Development and Therapy
|
journal
|
September 2013 |
|
Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer
|
journal
|
October 2013 |
|
HIV-1 neutralizing antibodies induced by native-like envelope trimers
|
journal
|
June 2015 |
|
Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen
|
journal
|
June 2015 |
|
HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen
|
journal
|
March 2016 |
|
Priming HIV-1 broadly neutralizing antibody precursors in human Ig loci transgenic mice
|
journal
|
September 2016 |
|
Activity of Broadly Neutralizing Antibodies, Including PG9, PG16, and VRC01, against Recently Transmitted Subtype B HIV-1 Variants from Early and Late in the Epidemic
|
journal
|
May 2011 |
|
Mechanism of Neutralization by the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01
|
journal
|
June 2011 |
|
Crystal Structure of PG16 and Chimeric Dissection with Somatically Related PG9: Structure-Function Analysis of Two Quaternary-Specific Antibodies That Effectively Neutralize HIV-1
|
journal
|
June 2010 |
|
Outer Domain of HIV-1 gp120: Antigenic Optimization, Structural Malleability, and Crystal Structure with Antibody VRC-PG04
|
journal
|
December 2012 |
|
A Native-Like SOSIP.664 Trimer Based on an HIV-1 Subtype B env Gene
|
journal
|
January 2015 |
|
HIV-1 Fitness Cost Associated with Escape from the VRC01 Class of CD4 Binding Site Neutralizing Antibodies
|
journal
|
January 2015 |
|
Analysis of a Clonal Lineage of HIV-1 Envelope V2/V3 Conformational Epitope-Specific Broadly Neutralizing Antibodies and Their Inferred Unmutated Common Ancestors
|
journal
|
July 2011 |
|
Subtypes of Human Immunodeficiency Virus Type 1 and Disease Stage among Women in Nairobi, Kenya
|
journal
|
January 1999 |
|
Access of Antibody Molecules to the Conserved Coreceptor Binding Site on Glycoprotein gp120 Is Sterically Restricted on Primary Human Immunodeficiency Virus Type 1
|
journal
|
September 2003 |
|
Neutralization Escape Variants of Human Immunodeficiency Virus Type 1 Are Transmitted from Mother to Infant
|
journal
|
December 2005 |
|
HIV-1 envelope glycoprotein signatures that correlate with the development of cross-reactive neutralizing activity
|
journal
|
January 2013 |
|
Differential binding of neutralizing and non-neutralizing antibodies to native-like soluble HIV-1 Env trimers, uncleaved Env proteins, and monomeric subunits
|
journal
|
January 2014 |
|
The carbohydrate at asparagine 386 on HIV-1 gp120 is not essential for protein folding and function but is involved in immune evasion
|
journal
|
January 2008 |
|
Few and Far Between: How HIV May Be Evading Antibody Avidity
|
journal
|
May 2010 |
|
A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies
|
journal
|
September 2013 |
|
Comprehensive Antigenic Map of a Cleaved Soluble HIV-1 Envelope Trimer
|
journal
|
March 2015 |
|
Sequential and Simultaneous Immunization of Rabbits with HIV-1 Envelope Glycoprotein SOSIP.664 Trimers from Clades A, B and C
|
journal
|
September 2016 |
|
Maturation Pathways of Cross-Reactive HIV-1 Neutralizing Antibodies
|
journal
|
November 2009 |
|
Anti-HIV B Cell Lines as Candidate Vaccine Biosensors
|
journal
|
October 2012 |
|
Structural basis for germline antibody recognition of HIV-1 immunogens
|
journal
|
March 2016 |